Cargando…
An in-silico approach to develop of a multi-epitope vaccine candidate against SARS-CoV-2 envelope (E) protein
Since the first appearance of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS- CoV-2) in China on December 2019, the world has now witnessed the emergence of the SARS- CoV-2 outbreak. Therefore, due to the high transmissibility rate of virus, there is an urgent need to design and develop v...
Autores principales: | Ghafouri, Fatemeh, Cohan, Reza Ahangari, Noorbakhsh, Farshid, Samimi, Hilda, Haghpanah, Vahid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336711/ https://www.ncbi.nlm.nih.gov/pubmed/32702713 http://dx.doi.org/10.21203/rs.3.rs-30374/v1 |
Ejemplares similares
-
Development of a Multiepitope Vaccine Against SARS-CoV-2: Immunoinformatics Study
por: Ghafouri, Fatemeh, et al.
Publicado: (2022) -
In-silico design and evaluation of an epitope-based serotype-independent promising vaccine candidate for highly cross-reactive regions of pneumococcal surface protein A
por: Afshari, Elnaz, et al.
Publicado: (2023) -
In silico analysis and in vivo assessment of a novel epitope-based vaccine candidate against uropathogenic Escherichia coli
por: Hasanzadeh, Sara, et al.
Publicado: (2020) -
Molecular evidence reveals thyrotropin intervention enhances the risk of developing radioiodine-refractory differentiated thyroid carcinoma
por: Samimi, Hilda, et al.
Publicado: (2022) -
In-silico design of envelope based multi-epitope vaccine candidate against Kyasanur forest disease virus
por: Arumugam, Sathishkumar, et al.
Publicado: (2021)